1055 related articles for article (PubMed ID: 33736695)
1. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
Huang Y; Wu Q; Tam PKH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
Front Immunol; 2019; 10():619. PubMed ID: 31001253
[TBL] [Abstract][Full Text] [Related]
6. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells - current trends and future prospective.
Ullah I; Subbarao RB; Rho GJ
Biosci Rep; 2015 Apr; 35(2):. PubMed ID: 25797907
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
Sadeghi S; Soudi S; Shafiee A; Hashemi SM
Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell secretome alters gene expression and upregulates motility of human endometrial stromal cells.
Zhao Q; Larios K; Naaldijk Y; Sherman LS; Chemerinski A; Okereke K; Rameshwar P; Lemenze A; Douglas NC; Morelli SS
Reproduction; 2023 Aug; 166(2):161-174. PubMed ID: 37252830
[TBL] [Abstract][Full Text] [Related]
11. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
[TBL] [Abstract][Full Text] [Related]
12. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
[TBL] [Abstract][Full Text] [Related]
14. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.
Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S
PLoS One; 2013; 8(1):e55319. PubMed ID: 23383153
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional cell culture (3DCC) improves secretion of signaling molecules of mesenchymal stem cells (MSCs).
Al-Shaibani MBH
Biotechnol Lett; 2022 Jan; 44(1):143-155. PubMed ID: 35000031
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
Yadav P; Vats R; Bano A; Bhardwaj R
Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine.
Carvalho MM; Teixeira FG; Reis RL; Sousa N; Salgado AJ
Curr Stem Cell Res Ther; 2011 Sep; 6(3):221-8. PubMed ID: 21476975
[TBL] [Abstract][Full Text] [Related]
18. Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease.
Keshavarz Shahbaz S; Mansourabadi AH; Jafari D
Clin Exp Immunol; 2022 May; 208(1):12-24. PubMed ID: 35274673
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
Front Immunol; 2020; 11():826. PubMed ID: 32435248
[No Abstract] [Full Text] [Related]
20. Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from
Mallis P; Chatzistamatiou T; Dimou Z; Sarri EF; Georgiou E; Salagianni M; Triantafyllia V; Andreakos E; Stavropoulos-Giokas C; Michalopoulos E
World J Biol Chem; 2022 Mar; 13(2):47-65. PubMed ID: 35432769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
